432 related articles for article (PubMed ID: 18516027)
1. Preoperative therapy in esophageal cancer.
Ku GY; Ilson DH
Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
[TBL] [Abstract][Full Text] [Related]
2. Esophageal cancer: adjuvant therapy.
Ku GY; Ilson DH
Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
[TBL] [Abstract][Full Text] [Related]
3. Preoperative therapy for esophageal cancer.
Ku GY; Ilson DH
Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
[TBL] [Abstract][Full Text] [Related]
4. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
5. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
8. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
Yano M; Inoue M; Shiozaki H
Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
[TBL] [Abstract][Full Text] [Related]
9. [Radio- and chemotherapy of cancer of the esophagus].
Tiret E
Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
[TBL] [Abstract][Full Text] [Related]
10. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.
Geh JI; Crellin AM; Glynne-Jones R
Br J Surg; 2001 Mar; 88(3):338-56. PubMed ID: 11260097
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy and chemoradiotherapy in the treatment of esophageal cancer].
Ando N; Ozawa S; Miki H; Suwa T; Kitajima M
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1878-85. PubMed ID: 7487116
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma.
Mooney MM
J Surg Oncol; 2005 Dec; 92(3):230-8. PubMed ID: 16299790
[TBL] [Abstract][Full Text] [Related]
13. [New strategies in the treatment of esophageal cancer].
Bidoli P; Aglione S; Toffolatti L; De Candis D; Bajetta E
Minerva Chir; 2002 Dec; 57(6):717-31. PubMed ID: 12592216
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative radiochemotherapy in esophageal carcinoma].
Stahl M
Praxis (Bern 1994); 1996 Mar; 85(10):303-6. PubMed ID: 8628959
[TBL] [Abstract][Full Text] [Related]
15. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
16. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy.
Tomimaru Y; Yano M; Takachi K; Miyashiro I; Ishihara R; Nishiyama K; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2006 Apr; 93(5):422-8. PubMed ID: 16550581
[TBL] [Abstract][Full Text] [Related]
18. [Place of neoadjuvant treatments in oesophageal cancers care].
Créhange G; Lorchel F; Bosset JF
Bull Cancer; 2006 Nov; 93(11):1107-13. PubMed ID: 17145580
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization.
Kleinberg L; Gibson MK; Forastiere AA
Nat Clin Pract Oncol; 2007 May; 4(5):282-94. PubMed ID: 17464336
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
